Literature DB >> 3044647

Determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates by means of stable isotope dilution technique, making use of deuterated cholic acid and chenodeoxycholic acid.

B J Koopman1, F Kuipers, C M Bijleveld, J C van der Molen, G T Nagel, R J Vonk, B G Wolthers.   

Abstract

A procedure is described for the simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates. After oral administration of known amounts of 11,12-dideuterated chenodeoxycholic acid and 2,2,4,4-tetradeuterated cholic acid, the ratios of chenodeoxycholic acid-D2/chenodeoxycholic acid and cholic acid-D4/cholic acid are measured in consecutive serum samples, after which fractional turnover rates and pool sizes of chenodeoxycholic acid and cholic acid are determined arithmetically. In 7 healthy volunteers pool sizes for chenodeoxycholic acid and cholic acid were 22.9 +/- 7.8 and 24.1 +/- 11.7 mumol/kg, respectively. The corresponding values for the fractional turnover rates were 0.23 +/- 0.10 and 0.29 +/- 0.12/day. After oral administration of the labelled bile acids in capsule, the obtained pool sizes were significantly higher than after administration in a bicarbonate solution. Bile acid kinetics were also performed in a patient suffering from a cholesterol synthesis deficiency and in a patient very likely suffering from a bile acid synthesis deficiency. Furthermore, the kinetics of the intestinal absorption and hepatic clearance of unconjugated bile acids have been investigated in 2 healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3044647     DOI: 10.1016/0009-8981(88)90004-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  A patient with mevalonic aciduria presenting with hepatosplenomegaly, congenital anaemia, thrombocytopenia and leukocytosis.

Authors:  J B de Klerk; M Duran; L Dorland; H A Brouwers; L Bruinvis; D Ketting
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 2.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

3.  Ursodeoxycholic acid accelerates bile acid enterohepatic circulation.

Authors:  Yunjing Zhang; Runqiu Jiang; Xiaojiao Zheng; Sha Lei; Fengjie Huang; Guoxiang Xie; Sandi Kwee; Herbert Yu; Christine Farrar; Beicheng Sun; Aihua Zhao; Wei Jia
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

Review 4.  The use of stable and radioactive sterol tracers as a tool to investigate cholesterol degradation to bile acids in humans in vivo.

Authors:  Marco Bertolotti; Andrea Crosignani; Marina Del Puppo
Journal:  Molecules       Date:  2012-02-16       Impact factor: 4.411

5.  Population pharmacokinetic model to generate mechanistic insights in bile acid homeostasis and drug-induced cholestasis.

Authors:  Véronique M P de Bruijn; Ivonne M C M Rietjens; Hans Bouwmeester
Journal:  Arch Toxicol       Date:  2022-07-25       Impact factor: 6.168

Review 6.  Role of bile acids in inflammatory liver diseases.

Authors:  Ioannis Evangelakos; Joerg Heeren; Esther Verkade; Folkert Kuipers
Journal:  Semin Immunopathol       Date:  2021-07-08       Impact factor: 9.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.